Meyka Pro banner
Sera Prognostics, Inc.

Sera Prognostics, Inc. Fundamental Analysis (NASDAQ: SERA)

SERANASDAQ
HealthcareMedical - Diagnostics & Research
$2.18
$0.00(0.00%)
U.S. Market opens in NaNh NaNm

Sera Prognostics, Inc. Fundamental Analysis (NASDAQ: SERA)

Sera Prognostics, Inc. (NASDAQ: SERA) shows moderate financial fundamentals with a PE ratio of -3.27, profit margin of -474.76%, and ROE of -46.71%. The company generates $0.0B in annual revenue with moderate year-over-year growth of 5.19%.

Key Strengths

Cash Position42.21%
PEG Ratio-0.14
Current Ratio1.98

Areas of Concern

ROE-46.71%
Operating Margin-532.83%
We analyze SERA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -35619.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-35619.3/100

We analyze SERA's fundamental strength across five key dimensions:

Efficiency Score

Weak

SERA struggles to generate sufficient returns from assets.

ROA > 10%
-38.31%

Valuation Score

Excellent

SERA trades at attractive valuation levels.

PE < 25
-3.27
PEG Ratio < 2
-0.14

Growth Score

Excellent

SERA delivers strong and consistent growth momentum.

Revenue Growth > 5%
5.19%
EPS Growth > 10%
32.32%

Financial Health Score

Excellent

SERA maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
1.98

Profitability Score

Weak

SERA struggles to sustain strong margins.

ROE > 15%
-4671.00%
Net Margin ≥ 15%
-474.76%
Positive Free Cash Flow
No

Key Financial Metrics

Is SERA Expensive or Cheap?

P/E Ratio

SERA trades at -3.27 times earnings. This suggests potential undervaluation.

-3.27

PEG Ratio

When adjusting for growth, SERA's PEG of -0.14 indicates potential undervaluation.

-0.14

Price to Book

The market values Sera Prognostics, Inc. at 1.86 times its book value. This may indicate undervaluation.

1.86

EV/EBITDA

Enterprise value stands at -2.72 times EBITDA. This is generally considered low.

-2.72

How Well Does SERA Make Money?

Net Profit Margin

For every $100 in sales, Sera Prognostics, Inc. keeps $-474.76 as profit after all expenses.

-474.76%

Operating Margin

Core operations generate -532.83 in profit for every $100 in revenue, before interest and taxes.

-532.83%

ROE

Management delivers $-46.71 in profit for every $100 of shareholder equity.

-46.71%

ROA

Sera Prognostics, Inc. generates $-38.31 in profit for every $100 in assets, demonstrating efficient asset deployment.

-38.31%

Following the Money - Real Cash Generation

Operating Cash Flow

Sera Prognostics, Inc. generates limited operating cash flow of $-20.94M, signaling weaker underlying cash strength.

$-20.94M

Free Cash Flow

Sera Prognostics, Inc. generates weak or negative free cash flow of $-21.30M, restricting financial flexibility.

$-21.30M

FCF Per Share

Each share generates $-0.56 in free cash annually.

$-0.56

FCF Yield

SERA converts -34.28% of its market value into free cash.

-34.28%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-3.27

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.14

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.86

vs 25 benchmark

P/S Ratio

Price to sales ratio

1194.83

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.98

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.47

vs 25 benchmark

ROA

Return on assets percentage

-0.38

vs 25 benchmark

ROCE

Return on capital employed

-0.60

vs 25 benchmark

How SERA Stacks Against Its Sector Peers

MetricSERA ValueSector AveragePerformance
P/E Ratio-3.2732.14 Better (Cheaper)
ROE-46.71%550.00% Weak
Net Margin-47475.71%30133.00% Weak
Debt/Equity0.000.56 Strong (Low Leverage)
Current Ratio1.985.70 Neutral
ROA-38.31%3.00% Weak

SERA outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Sera Prognostics, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

23.09%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

38.89%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

42.29%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ